SynthesisBMC pharmacology & toxicology2015

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.

Andrea C Tricco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.